<DOC>
	<DOCNO>NCT00784693</DOCNO>
	<brief_summary>The purpose study determine whether tanezumab effective safe treatment pain associate endometriosis .</brief_summary>
	<brief_title>A Clinical Study To Investigate The Effectiveness And Safety Of Tanezumab In Treating Pain Associated With Endometriosis</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<criteria>Premenstrual woman moderate severe endometriosis . The diagnosis endometriosis must confirm surgically within last 8 year . Subjects regular menstrual cycle ( 21 35 day ) must willing use adequate contraception ( 2 form birth control , one must barrier method ) . Contraception require throughout study ( screen 16 week post treatment ) , even subject discontinue prematurely . Previous hysterectomy Surgical treatment endometriosis within last 6 month . Medical treatment endometriosis combine oral contraceptive pill within last 3 month Current use coil progesterone contraceptive ( combined oral contraceptive pill allow ) . Any history malignant disease ( cancer )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>Endometriosis</keyword>
	<keyword>pain</keyword>
	<keyword>tanezumab</keyword>
	<keyword>nerve growth factor</keyword>
	<keyword>questionnaire</keyword>
</DOC>